https://www.selleckchem.com/pr....oducts/vu0463271.htm
Immune-related hepatitis (IRH) is a frequent but poorly understood immune-related adverse event and its frequency increases since the use of combination therapy in several cancer types. Therefore, there is an urgent need to develop adapted guidelines to manage IRH.In the present letter, based on Ziogas et al report entitled 'When steroids are not enough in immune-related hepatitis current clinical challenges discussed on the basis of a case report', several points are discussed assessment of IRH severity and liver biopsy indication, i
Like
Comment
Share
